How to Get Revcovi (elapegademase) Covered by Aetna CVS Health in Virginia: Complete PA Guide with Forms and Appeal Steps
Answer Box: Getting Revcovi Covered by Aetna CVS Health in Virginia
Revcovi (elapegademase) requires prior authorization from Aetna CVS Health but is covered on the specialty tier for confirmed ADA-SCID cases. Submit a complete PA packet including genetic/enzyme testing, specialist documentation, and transplant failure evidence through the Aetna provider portal. Standard approval takes 24-48 hours; expedited decisions within 72 hours if medically urgent. If denied, Virginia's Bureau of Insurance provides external review within 45 days (72 hours expedited).
First step today: Have your immunologist verify your Aetna plan type and submit the PA packet via the provider portal with complete diagnostic documentation.
Table of Contents
- Plan Types & Network Requirements
- Formulary Status & Tier Placement
- Prior Authorization Requirements
- CVS Specialty Pharmacy Setup
- Cost Sharing & Financial Assistance
- Submission Process & Timelines
- Appeals Process in Virginia
- Common Approval Patterns
- When to Escalate
- FAQ
Plan Types & Network Requirements
Aetna CVS Health offers several plan types in Virginia, each with different referral and network requirements for Revcovi coverage:
Commercial Plans (HMO/PPO/EPO)
- HMO plans require primary care referrals to immunology specialists
- PPO/EPO plans allow direct specialist access but in-network providers reduce costs
- All plans require PA for Revcovi regardless of network status
Medicare Advantage
- Follow Medicare Part B coverage rules for specialty injectables
- May have additional step therapy requirements
- Expedited appeals available for urgent medical needs
Medicaid Plans
- Virginia expanded Medicaid covers specialty drugs with PA
- May require state-specific forms in addition to Aetna requirements
Tip: Check your member ID card for plan type (HMO, PPO, EPO) and contact member services to confirm specialty pharmacy benefits before starting the PA process.
Formulary Status & Tier Placement
Revcovi sits on Aetna's specialty drug tier for 2025-2026 formularies. Here's what this means:
| Coverage Element | Status | What It Means |
|---|---|---|
| Formulary Listed | Yes | Covered with PA |
| Tier Placement | Specialty | Highest cost-sharing tier |
| PA Required | Yes | Must prove medical necessity |
| Step Therapy | Case-by-case | May require transplant failure documentation |
| Quantity Limits | Per weight/dose | Based on FDA dosing guidelines |
Key Point: Revcovi is covered under the medical benefit, not pharmacy benefit, due to required clinical administration and cold storage via CVS Specialty.
Alternative Therapies: If Revcovi is denied, your specialist may consider:
- Hematopoietic stem cell transplant (if eligible)
- Clinical trial gene therapies
- Supportive care protocols
Prior Authorization Requirements
Aetna requires comprehensive documentation for Revcovi PA approval. Here's exactly what you need:
Core Documentation Checklist
Diagnosis Confirmation
- ADA enzyme activity test showing <1% of normal levels
- Genetic testing confirming pathogenic ADA mutations
- ICD-10 code D81.3 (ADA-SCID) documented
Specialist Requirements
- Prescribing immunologist, hematologist/oncologist, or geneticist
- Current specialist notes (within 30 days)
- Treatment plan specifying 0.2-0.4 mg/kg weekly IM dosing
Prior Therapy Documentation
- Bone marrow transplant failure, ineligibility, or contraindication
- Gene therapy consideration status
- Previous ADA enzyme replacement attempts (if any)
Clinical Monitoring
- Current CBC with platelet count ≥50,000/μL
- Patient weight for dosing calculations
- Baseline lymphocyte counts
Medical Necessity Letter Template
Your specialist should include these elements in their letter:
- Patient presentation: ADA-SCID diagnosis with specific enzyme/genetic results
- Treatment rationale: Why Revcovi is medically necessary vs. alternatives
- Prior therapy failures: Transplant contraindications or failures
- Expected outcomes: Improved immune function, reduced infections
- Monitoring plan: Regular lab work, dose adjustments, safety assessments
CVS Specialty Pharmacy Setup
Revcovi must be dispensed through CVS Specialty Pharmacy due to cold storage requirements. Here's the enrollment process:
Six-Step Enrollment Process
- Patient Information: Complete demographics, contact details, consent for automated updates
- Insurance Details: Medical and prescription coverage, copay assistance enrollment
- Diagnosis: ICD-10 code D81.3 with clinical description
- Clinical Information: Allergies, current medications, height/weight
- Prescription Details: Revcovi strength, dose, quantity, refills
- Prescriber Signature: Required authorization for PA submission
Submission Methods
Electronic: Use ePrescribe code 1466033 to CVS Specialty Phone: 1-800-237-2767 (7 days/week) Fax: 1-800-323-2445
Additional Requirement: Patients must also enroll in Chiesi Total Care (manufacturer support program) using their separate enrollment form.
Note: No Virginia-specific setup requirements exist. The standard nationwide CVS Specialty process applies for all patients.
Cost Sharing & Financial Assistance
Revcovi costs approximately $11,851 per 1.5 mL vial, with actual out-of-pocket costs varying by plan design.
Typical Cost Structure
| Plan Type | Patient Responsibility |
|---|---|
| Commercial PPO | 20-40% coinsurance after deductible |
| Commercial HMO | $50-200 specialty copay |
| Medicare Advantage | 25-33% coinsurance |
| Medicaid | $0-3 copay |
Financial Assistance Options
Manufacturer Support: Chiesi Total Care provides:
- Copay assistance for eligible commercial patients
- Prior authorization support
- Adherence monitoring and education
State Programs: Virginia residents may qualify for:
- Virginia Medicaid (expanded eligibility)
- State pharmaceutical assistance programs
- Hospital charity care programs
Foundation Grants: Organizations like Patient Services Inc. and Good Days offer grants for rare disease treatments.
Submission Process & Timelines
Fastest Path to Approval
- Verify Coverage (Day 1): Check plan type and specialty pharmacy benefits
- Gather Documents (Days 1-3): Collect all diagnostic and clinical records
- Submit PA (Day 4): Electronic submission via Aetna provider portal
- Track Status (Days 5-7): Monitor for additional information requests
- Receive Decision (Days 1-2 post-submission): Standard timeline 24-48 hours
- Set Up Specialty Pharmacy (Upon approval): Enroll with CVS Specialty
- Coordinate Delivery (Within 1-2 business days): Schedule first shipment
Timeline Expectations
| Request Type | Standard Timeline | Expedited Timeline |
|---|---|---|
| Initial PA | 24-48 hours | 24-72 hours |
| Additional Info | 5 days | 24 hours |
| Internal Appeal | 30-60 days | 72 hours |
| External Review | 45 days | 72 hours |
Request expedited review if delay risks serious harm (requires physician documentation).
Appeals Process in Virginia
Virginia provides robust appeal rights through the State Corporation Commission Bureau of Insurance.
Internal Appeals (Aetna)
Timeline: File within 60 days of denial Process: Submit additional evidence, request peer-to-peer review Decision: 30-60 days standard, 72 hours expedited
External Review (Virginia Bureau of Insurance)
Eligibility: Complete internal appeals first Timeline: 120 days from final denial to file Process: Submit Form 216-A with supporting documentation Decision: 45 days standard, 72 hours expedited
Required Documents for External Review
- Denial notice from Aetna
- Complete medical records
- Provider recommendations
- Plan terms and coverage policies
- Written explanation of alleged policy violations
Contact Information: Virginia Bureau of Insurance P.O. Box 1157, Richmond, VA 23218 Phone: (804) 371-9747 Email: [email protected]
Virginia Advantage: The state allows expedited external review for cancer treatments without exhausting internal appeals—a provision that may apply to life-threatening immunodeficiency cases.
Common Approval Patterns
Based on successful Revcovi approvals, strong submissions typically include:
Documentation That Works
Genetic Evidence: Clear pathogenic ADA mutations with clinical correlation Specialist Expertise: Letters from recognized immunology centers Transplant Status: Detailed explanation of ineligibility or failure Clinical Urgency: Evidence of recurrent infections, failure to thrive Monitoring Plan: Comprehensive safety and efficacy tracking
Red Flags That Cause Denials
- Incomplete genetic/enzyme testing
- Off-label use without strong justification
- Missing transplant consideration documentation
- Inadequate specialist involvement
- Unclear dosing rationale
From our advocates: "Patients who succeed often have their immunologist call Aetna directly for a peer-to-peer review when the initial PA is incomplete. This conversation frequently resolves documentation gaps and speeds approval."
When to Escalate
Contact Virginia regulators if you encounter:
- Repeated denials despite complete documentation
- Failure to meet Virginia timeline requirements
- Discrimination based on disability or age
- Improper application of medical necessity criteria
Virginia State Corporation Commission Bureau of Insurance provides free consumer assistance and can investigate potential violations of state insurance law.
FAQ
How long does Aetna CVS Health PA take in Virginia? Standard PA decisions are made within 24-48 hours. Expedited requests for urgent medical needs are decided within 72 hours.
What if Revcovi is non-formulary on my specific plan? Request a formulary exception with medical necessity documentation. Most ADA-SCID cases qualify due to lack of therapeutic alternatives.
Can I request an expedited appeal in Virginia? Yes, if delay jeopardizes life or health. Your physician must document the urgency. Virginia's external review can be expedited to 72 hours.
Does step therapy apply if I've tried treatments outside Virginia? Yes, Aetna accepts prior therapy documentation from any state. Ensure your Virginia specialist has complete records of previous treatments.
What happens if my appeal is denied? Virginia's external review decision is binding on Aetna. If upheld, consider consultation with a healthcare attorney or patient advocacy organization.
How often do I need PA renewal? Typically every 30-45 days before authorization expires. Include updated labs showing treatment response (trough ADA activity ≥30 mmol/hr/L).
About Counterforce Health: Counterforce Health specializes in turning insurance denials into successful appeals for complex medications like Revcovi. Our platform analyzes denial letters, identifies specific coverage criteria, and generates evidence-backed appeals tailored to each payer's requirements—helping patients, clinicians, and specialty pharmacies navigate the prior authorization process more effectively.
Sources & Further Reading
- Aetna Provider Portal and PA Requirements
- CVS Specialty Pharmacy Enrollment Forms
- Virginia Bureau of Insurance External Review Process
- Virginia State Corporation Commission Consumer Services
- FDA Revcovi Prescribing Information
- Revcovi HCP Ordering and Support
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage decisions vary by individual plan and clinical circumstances. Always consult with your healthcare provider and insurance plan for specific guidance. For additional support with Virginia insurance issues, contact the Virginia State Corporation Commission Bureau of Insurance at (804) 371-9747.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.